GCA
Gradient Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Hold |
384
| – | – | 0.06% | 158 |
|
|
2025
Q1 | $244K | Hold |
384
| – | – | 0.08% | 139 |
|
|
2024
Q4 | $274K | Hold |
384
| – | – | 0.09% | 129 |
|
|
2024
Q3 | $404K | Hold |
384
| – | – | 0.13% | 103 |
|
|
2024
Q2 | $404K | Hold |
384
| – | – | 0.14% | 101 |
|
|
2024
Q1 | $370K | Hold |
384
| – | – | 0.14% | 111 |
|
|
2023
Q4 | $337K | Hold |
384
| – | – | 0.13% | 114 |
|
|
2023
Q3 | $316K | Hold |
384
| – | – | 0.13% | 107 |
|
|
2023
Q2 | $276K | Hold |
384
| – | – | 0.11% | 125 |
|
|
2023
Q1 | $316K | Hold |
384
| – | – | 0.13% | 107 |
|
|
2022
Q4 | $277K | Hold |
384
| – | – | 0.13% | 114 |
|
|
2022
Q3 | $265K | Buy |
+384
| New | +$265K | 0.13% | 108 |
|